We are live on ! Find out more
PBPIA

Pivotal bioVenture Partners Investment Advisor Portfolio holdings

AUM $280M
1-Year Est. Return 181.4%
This Fund
S&P 500
This Quarter Est. Return
+21.51%
1 Year Est. Return
+181.4%
3 Year Est. Return
+730.97%
5 Year Est. Return
+1,157.4%
10 Year Est. Return
–
AUM
$303M
AUM Growth
+$60.5M
Cap. Flow
+$13.3M
Cap. Flow %
4.39%
Top 10 Hldgs %
99.76%
Holding
11
New
–
Increased
3
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
ARQT icon
Arcutis Biotherapeutics
ARQT
+$5.95M
2
PCVX icon
Vaxcyte
PCVX
+$4.74M
3
INZY
Inozyme Pharma
INZY
+$2.65M

Top Sells

Rank Stock Value
1
EXAI
Exscientia Plc American Depositary Shares
EXAI
+$10.9K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$170M 55.9%
782,008
– –
PCVX icon
2
Vaxcyte
PCVX
$8.81B
$39.6M 13.06%
793,036
+99,997
+14% +$4.74M
OCS icon
3
Oculis Holding
OCS
$708M
$29.4M 9.68%
2,381,196
– –
INZY
4
DELISTED
Inozyme Pharma
INZY
$20.4M 6.72%
3,661,518
+447,932
+14% +$2.65M
RLYB icon
5
Rallybio
RLYB
$87M
$13.6M 4.49%
300,581
– –
ARQT icon
6
Arcutis Biotherapeutics
ARQT
$3.3B
$10.5M 3.47%
1,105,309
+536,268
+94% +$5.95M
FUSN
7
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$7.29M 2.4%
1,560,982
– –
VIGL
8
DELISTED
Vigil Neuroscience
VIGL
$5.27M 1.74%
560,595
– –
EXAI
9
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$4.56M 1.5%
770,500
-1,785
-0.2% -$10.9K
BOLT icon
10
Bolt Biotherapeutics
BOLT
$7.65M
$2.42M 0.8%
94,573
– –
ALGS icon
11
Aligos Therapeutics
ALGS
$45.5M
$722K 0.24%
29,729
– –

Similar funds

HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
CCC
Compass Capital Corp Braintree, Massachusetts $279M AUM 28.36% 1-Year Est. Return
PHC
Panoramic Hills Capital Road Town $280M AUM
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor's Q2 2023 Portfolio in Review

As of Q2 2023, Pivotal bioVenture Partners Investment Advisor held 11 positions worth $303M, up 25% from $243M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Pivotal bioVenture Partners Investment Advisor deployed $13.3M of net new capital in Q2 2023, adding to 3 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Exscientia Plc American Depositary Shares, an estimated $10.9K trimmed.

  • Pivotal bioVenture Partners Investment Advisor added most to Arcutis Biotherapeutics in Q2 2023, an estimated $5.95M increase.
  • Pivotal bioVenture Partners Investment Advisor's biggest Q2 2023 reduction was Exscientia Plc American Depositary Shares, cutting an estimated $10.9K.
  • Pivotal bioVenture Partners Investment Advisor's ten largest holdings make up 100% of its $303M portfolio in Q2 2023.
  • Pivotal bioVenture Partners Investment Advisor opened 0 new positions and closed 0 in Q2 2023.
  • Pivotal bioVenture Partners Investment Advisor's portfolio value rose 25% quarter-over-quarter to $303M.

Based on Pivotal bioVenture Partners Investment Advisor's 13F filing for Q2 2023, filed 11 Aug 2023.